Kute VB, Prasad N, Shah PR, Modi PR. Kidney exchange transplantation current status, an update and future perspectives. World J Transplant 2018; 8(3): 52-60 [PMID: 29988896 DOI: 10.5500/wjt.v8.i3.52]
Corresponding Author of This Article
Vivek B Kute, FCPS, MBBS, MD, Professor, Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases and Research Centre, Dr Trivedi Institute of Transplantation Sciences, Ahmedabad 380016, India. drvivekkute@rediffmail.com
Research Domain of This Article
Transplantation
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
High transplant rate for highly sensitized, HLA-incompatible pairs due to accepting ABO-incompatible donor matching with ABO titers ≤ 1:64, high-resolution HLA identification and virtual cross match
Use of compatible pairs and A2 donors increases transplant rate even in single canter program
National kidney registry, United States
Longer chain are used in matching
Donor vs kidney transport
Donors travel is preferred in Netherlands and Canada, kidney transport is preferred in United Kingdom and Australia
Alliance for paired donation, United States
Global kidney exchange
Table 4 Strength and weakness of international kidney exchange
Strength
Weakness
Increase access to better and effective health care of end stage renal disease patients for transplantation
Inequalities between donor recipient pairs from participating countries result from differences in regulatory, legal and reimbursement policy. Increase inequality and inequity in participating countries particularly for low/middle income countries
Quality of medical care increase from existing and participating National programs
Logistics are complex in immunological evaluation of pairs, management of clinical data and simultaneous surgery
Increase pool size, optimization and diversity of pairs increase quality of matching, number of transplants and increase transplant rate for difficult to match pairs who remain unmatched within their own country
Emerging less well established programs are likely to benefit less than well-funded established program. Limiting development of national program to become self-sufficient in organ donation and transplantation
Mutual learning between different National programs. Promote collaboration, best practice and spread of kidney exchange in interested countries
Adequate financial support for effective and equitable follow-up must be available in low/middle income countries
Risk for donor recipient pairs with less adequate health care system to manage medical complications and long term follow up care
Facilitate legal, ethical expansion of kidney exchange program with International organ donation and transplantation community
Risks reducing the effectiveness and equity of existing well established program due to practical, logistical and organisational considerations associated with trans-national kidney exchange program
Dialysis is replaced with kidney exchange which is best and cost effective living donor kidney transplantation
Reputational risk and loss of public trust interest confidence in organ donation and transplantation if international kidney exchange involve Nations without appropriate legal and ethical policy to support best practice
Table 5 Advantages of global kidney exchange[50-53]
2-7 million people die World-wide from kidney failure due to poverty. Helping some of these poor patients would be good. GKE helps only those patients who have exhausted all the solutions in their home country and increases transplant opportunity for poor patients from low/middle income countries who are otherwise exposed to death[61-62]
GKE wants to support poor patients from low/middle income country legally, ethically, fairly and transparently following the rules established by the National Competent Authorities of each country
GKE does not induce donation but removes the financial barrier to donation for a willing donor recipient pairs where donor’s motivation is altruistic and unpaid
Everybody wins in GKE: Low/middle income country’s donor and recipient, low/middle income country’s pre-and post-transplantation health care system, high income country’s recipient, health care payers and high income country’s Government and taxpayers
GKE can send high income country patient to high quality low/middle income country transplant centers, instead of reverse. This would be less expensive and build local infrastructure in low/middle income country and access to kidney transplantation to more low/middle income country patients
There can be oversight by organizations such as the World Health Organization and the Transplantation Society with strong International governance that is consistent with the highest ethical and legal standards
Citation: Kute VB, Prasad N, Shah PR, Modi PR. Kidney exchange transplantation current status, an update and future perspectives. World J Transplant 2018; 8(3): 52-60